AI and Genomics: A New Approach to Treating Genetic Disorders
Researchers at the Australian National University (ANU) have combined AI technology with genome sequencing to advance the diagnosis and treatment of genetic diseases. Using Google DeepMind’s AlphaFold, an AI system for predicting protein structures, the team studied the effects of all possible mutations across human proteins, uncovering patterns that could inform healthcare practices.
The research, published in Nature Communications, revealed that evolution has made essential proteins more resistant to harmful mutations. Associate Professor Dan Andrews, who led the study, explained that while some proteins are built to withstand mutations, others lack this resilience, which can result in disease.
This discovery challenges traditional views on gene importance in disease onset. “Genetic mutations are inevitable, but not all genes are equally protected. Some critical genes rarely show mutations in people, while others, less vital but still important, can cause disease when mutated,” Andrews noted.
Impact on Treatment Strategies
The study supports the development of AI-based tools that can identify dysfunctional genetic systems in patients. This capability allows healthcare providers to prioritize treatment options based on an individual’s unique genetic profile. The approach is especially relevant for complex diseases involving multiple mutations, as it scores genetic variations by their functional effects.
By pinpointing which genes are affected, clinicians can potentially select more effective treatments, improving patient outcomes.
Relevance to India’s Healthcare Sector
India’s healthcare system, with its focus on personalised medicine and biotechnology, stands to gain significantly from this research. The country faces challenges in diagnosing and treating rare genetic disorders due to limited access to advanced genomics and molecular diagnostics.
Integrating AI tools like those developed by the ANU team could enhance diagnostic accuracy in both tertiary and secondary care centers. Given India’s vast and genetically diverse population, precision medicine can help map genetic vulnerabilities and guide patient-specific interventions.
Government initiatives such as the National Digital Health Mission (NDHM) and Genome India Project provide a strong foundation for implementing these AI-driven solutions. These advances can reduce misdiagnoses, lower costs, and support clinical decisions, especially in regions with limited resources.
Collaboration between Indian biotech firms, startups, and global research institutions could accelerate the adoption of AI-powered genetic screening and personalised treatment algorithms. Andrews highlighted future goals to develop automated systems that identify effective treatments using genetic and pathology data.
Looking Ahead
The ANU research marks a significant step in using AI to improve precision medicine. For Indian healthcare professionals, from hospital networks to diagnostic labs, these tools offer a path to more data-informed, targeted care.
As India moves toward value-based healthcare models, adopting AI solutions for genetic disease management can improve treatment effectiveness and patient outcomes nationwide.
Your membership also unlocks:
